"Breakthroughs That Change Patients' Lives"
Table of Contents
1. Company Snapshot
🌍 Headquarters: New York City, USA
🌐 Global Presence: 125+ countries
📅 Founded: 1849 | 🏦 Public: NYSE: PFE
👥 Employees: 83,000+ (17% in R&D)
💻 Careers: Pfizer Careers
2. Mission, Vision & Values
🧬 Mission:
“To innovate to bring therapies to patients that significantly improve their lives”
👁️ Vision:
“A healthier world through science”
🌟 Core Values:
- Courage (Scientific boldness)
- Excellence
- Equity (Global health access)
Culture: 4.0/5 Glassdoor | “Fast-paced science-driven environment”
3. Key Leadership
| Role | Name | Leadership Style |
|---|---|---|
| CEO | Dr. Albert Bourla | Science-first innovator |
| CFO | Dave Denton | Financial strategist |
4. Key Milestones
1950: Developed Terramycin (first US-approval antibiotic)
1998: Launched Viagra
2020: COVID-19 vaccine developed in record time
2023:
- Seagen acquisition ($43B)
- Paxlovid reached $18B sales
5. Business Model & Position
💰 Revenue Streams:
- 55% Vaccines & Therapeutics
- 30% Oncology
- 15% Internal Medicine
🆚 Key Competitors:
| Company | Headquarters | Focus Area |
|---|---|---|
| Johnson & Johnson | New Jersey, USA | Diversified healthcare |
| Merck | New Jersey, USA | Oncology leader |
6. Industry Trends & Challenges
📈 Opportunities:
- mRNA technology expansion
- Cancer immunotherapy growth
- Emerging markets access
⚠️ Challenges:
- Patent cliffs (2025-2030)
- Drug pricing pressures
7. Financial Health (2023)
| Metric | Value | Industry Avg |
|---|---|---|
| Revenue | $58.5B | $45.2B |
| R&D Investment | $10.7B | $8.3B |
| Net Margin | 31% | 22% |
8. SWOT Analysis
💪 Strengths:
- #1 vaccine manufacturer
- Strong oncology pipeline
📉 Weaknesses:
- Over-reliance on COVID products
- Pipeline gaps in neurology
🌱 Opportunities:
- Seagen integration
- Gene therapy advancements
⚠️ Threats:
- Biosimilar competition
- Political drug pricing reforms
9. Recent Developments
🔬 Research:
- 78 new clinical trials initiated (2023)
- RSV vaccine Abrysvo launch
🤝 Partnerships:
- BioNTech mRNA collaboration extended
- Developing countries vaccine access program
10. Interview Toolkit
Must-Know:
- CEO’s “Science Will Win” philosophy
- 2025 patent cliff strategy
Smart Questions:
“How is Pfizer diversifying beyond COVID-related revenues?”
11. Conclusion
Pfizer leads global pharma through:
🔹 Unmatched vaccine expertise
🔹 Strategic acquisitions (Seagen)
🔹 Commitment to global health equity
Ideal for: R&D scientists, regulatory affairs, and commercial professionals.